Impact of Unapproved Drug Initiative on Colchicine Use

Completed

Conditions studied: Gout

In brief

Measure if FDA regulation of Colchicne in 2009 has resulted in safer use in clinical settings. Our study will assess the impact of this Initiative on colchicine use and will provide data that supports its continuation and expansion.

Key facts

Study ID

NCT02000232

Run by

Stanford University

People needed

185

Starts

2013-01-01

Expected to finish

2014-09-01

Last updated by the study team

2022-08-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinical diagnosis of gout
• Current use of colchicine/colcrys to treat gout
• Ablility to provide Informed consent

You may not qualify if…

• Inability to provide Informed consent

Where it is running

• Stanford Hospital and Clinics — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.